Novo Nordisk Pharmatech has attracted an extensive roster of leading pharmaceutical companies through unsurpassed product quality, manufacturing and quality control, regulatory documentation, precision delivery and a comprehensive risk mitigation strategy.
The company is the leading worldwide supplier of products such as recombinant insulin for cell growth media and pharmaceutical grade quaternary ammonium compounds (Quats) for the pharmaceutical and personal care industries.
Both are manufactured to cGMP standards and in both product areas the company has distinguished itself for the following:
- global regulatory compliance
- consistent high quality
- extensive regulatory documentation
- continuous availability
- secure global supply chain
- high levels of service and support
Novo Nordisk Pharmatech's quality system meets DS/EN ISO 9001 standards as well as the guidelines outlined in ICH Guide Q7 for Active Pharmaceutical Ingredients.
Meet Novo Nordisk Pharmatech at CPhI WW 2017; stand 80M43 / ZONE API
